Close Menu

NEW YORK — The Alzheimer's Drug Discovery Foundation (ADDF) said on Wednesday that it has partnered with four global pharmaceutical companies to create an Alzheimer's disease biobank for biomarker research.

ADDF also said that it has awarded nearly $3 million in new research grants supporting the development of new Alzheimer's disease diagnostic technologies.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Antibody testing is expected to play an important role in the management of the COVID-19 pandemic. 


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.